Estrogen class drugs

17 results

  • Annovera

    (segesterone acetate and ethinyl estradiol)
    TherapeuticsMD, Inc.
    Usage: ANNOVERA is indicated for females of reproductive potential to prevent pregnancy. It is not adequately studied in females with a BMI greater than 29 kg/m².

  • Balcoltra

    (levonorgestrel and ethinyl estradiol)
    Avion Pharmaceuticals
    Usage: Balcoltra is indicated for females of reproductive potential for the prevention of pregnancy.

  • Bijuva

    (estradiol and progesterone)
    Mayne Pharma LLC
    Usage: The drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.

  • Climara pro

    (Estradiol and Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Climara Pro is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis, specifically in women at significant risk. Non-estrogen medications should be considered first for osteoporosis prevention.

  • Estrogel

    (estradiol)
    ASCEND Therapeutics US, LLC
    Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy associated with menopause. For vulvar and vaginal atrophy, topical vaginal products should be considered first if symptoms are the sole concern.

  • Evamist

    (Estradiol)
    Padagis US LLC
    Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.

  • Imvexxy

    (estradiol)
    Mayne Pharma LLC
    Usage: This drug is indicated for the treatment of moderate to severe dyspareunia, which is a symptom of vulvar and vaginal atrophy resulting from menopause.

  • Lo loestrin fe

    (norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate)
    Allergan, Inc.
    Usage: Lo Loestrin® Fe is indicated for the prevention of pregnancy in women. Its efficacy in women with a BMI greater than 35 kg/m² has not been evaluated.

  • Myfembree

    (relugolix, estradiol hemihydrate, and norethindrone acetate)
    Sumitomo Pharma America, Inc
    Usage: MYFEMBREE is indicated for managing heavy menstrual bleeding associated with uterine leiomyomas and for treating moderate to severe pain related to endometriosis in premenopausal women. Usage is limited to 24 months due to the risk of irreversible bone loss.

  • Natazia

    (estradiol valerate and estradiol valerate/dienogest)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Natazia® is indicated for preventing pregnancy in women and for treating heavy menstrual bleeding in those without organic pathology who prefer an oral contraceptive. Efficacy in women with a BMI over 30 kg/m² has not been evaluated.